Christopher B. Primiano
2016
In 2016, Christopher B. Primiano earned a total compensation of $671.7K as Executive Vice President, Chief Business Officer, General Counsel and Secretary at Karyopharm Therapeutics, a 84% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $122,000 |
|---|---|
| Option Awards | $178,476 |
| Salary | $360,000 |
| Other | $11,260 |
| Total | $671,736 |
Primiano received $360K in salary, accounting for 54% of the total pay in 2016.
Primiano also received $122K in non-equity incentive plan, $178.5K in option awards and $11.3K in other compensation.
Rankings
In 2016, Christopher B. Primiano's compensation ranked 10,071st out of 14,075 executives tracked by ExecPay. In other words, Primiano earned more than 28.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,071 out of 14,075 | 28th |
Division Manufacturing | 3,889 out of 5,486 | 29th |
Major group Chemicals And Allied Products | 1,370 out of 1,900 | 28th |
Industry group Drugs | 1,095 out of 1,543 | 29th |
Industry Pharmaceutical Preparations | 858 out of 1,173 | 27th |
Source: SEC filing on April 27, 2018.
Primiano's colleagues
We found three more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2016.